JOURNAL OF THE LOUISIANA STATE MEDICAL SOCIETY
REFERENCES
1. George B, Bresson D, Herman P, Froelich S. Chordomas: A Review. Neurosurg Clin N Am . 2015;26(3):437-452. 2. Kayani B, Sewell MD, Hanna SA, et al. Prognostic factors in the operative management of dedifferentiated sacral chordomas. Neurosurgery. 2014;75(3):269-275; discussion 275. 3. Ruosi C, Colella G, Di Donato SL, Granata F, Di Salvatore MG, Fazioli F. Surgical treatment of sacral chordoma: survival and prognostic factors. Eur Spine J . 2015;24 Suppl 7:912-917. 4. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control . 2001;12(1):1-11. 5. Garofalo F, di Summa PG, Christoforidis D, et al. Multidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery. J Surg Oncol. 2015;112(5):544-554. 6. Kayani B, Hanna SA, Sewell MD, Saifuddin A, Molloy S, Briggs TW. A review of the surgical management of sacral chordoma. Eur J Surg Oncol. 2014;40(11):1412-1420. 7. Angelini A, Pala E, Calabro T, Maraldi M, Ruggieri P. Prognostic factors in surgical resection of sacral chordoma. J Surg Oncol. 2015;112(4):344-351. 8. Ruggieri P, Angelini A, Ussia G, Montalti M, Mercuri M. Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res. 2010;468(11):2939-2947. 9. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res . 1980(153):106-120. Racheal Wolfson, MD, is a resident at LSUHSC-Shreveport, Department of Neurosurgery. Richard Menger, MD, MPA, is chief resident at LSUHSC- Shreveport, Department of Neurosurgery. Ouyen Dinh Chu, MD, MBA , is a Professor of Surgery and Chief of Division of Surgical Oncology at LSUHSC- Shreveport, Department of Surgical Oncology. Anthony Sin, MD is an Associate Professor of Neurosurgery and Director of Complex Spinal Disorders at LSUHSC- Shreveport, Department of Neurosurgery.
Figure 6: Surgical scar after healing of posterior incision.
CONCLUSION
The gold standard for treatment of sacral chordoma remains en bloc resection with wide margins. These tumors are often diagnosed after they have grown to considerable size in the pelvis and should be referred to a specialized multidisciplinary center with experience. We advocate use of a team composed of surgical oncology and neurosurgery in order to carefully resect the tumor from the pelvic contents and spinal canal and reconstruct the lumbosacral support.
J La State Med Soc VOL 170 JANUARY/FEBRUARY 2018 9
Made with FlippingBook Digital Publishing Software